Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Elevance HealthMEX:ELV 80 Return-on-Tangible-Asset is 6.63% as of Jun. 2026, which is 25% below its 10-year median of 8.82. GuruFocus rates MEX:ELV with a GF Score™ of 80/100 and a GF Value™ of MXN8,129.50 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 18 Healthcare Plans companies, Elevance Health ranks better than 55.56% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Elevance Health's annualizedNet Income for the quarter that ended in Jun. 2026 was MXN102,112 Mil. Elevance Health's average total tangible assets for the quarter that ended in Jun. 2026 was MXN1,539,002 Mil. Therefore, Elevance Health's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2026 was 6.63%.
The historical rank and industry rank for Elevance Health's Return-on-Tangible-Asset or its related term are showing as below:
MEX:ELV'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 5.9 Med: 8.82 Max: 10.64
Current: 5.9
During the past 13 years, Elevance Health's highest Return-on-Tangible-Asset was 10.64%. The lowest was 5.90%. And the median was 8.82%.
MEX:ELV's Return-on-Tangible-Asset is ranked better than 55.56% of 18
companies
in the Healthcare Plans industry
Industry Median: 2.415
vs MEX:ELV: 5.90
Elevance Health (MEX:ELV) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Elevance Health Return-on-Tangible-Asset Related Terms
Elevance Health Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Elevance Health's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:ELV vs CI, HUM, CVS: Return-on-Tangible-Asset Comparison
For the Healthcare Plans subindustry, Elevance Health's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elevance Health Return-on-Tangible-Asset vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Elevance Health's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Elevance Health's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 6.63% mean?
Elevance Health (MEX:ELV) has a Return-on-Tangible-Asset of 6.63% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Elevance Health and its competitors. This is 25% below median its historical median of 8.82. Over the past decade, Elevance Health's Return-on-Tangible-Asset has ranged from 5.90 to 10.64. According to the industry distribution chart, Elevance Health ranks #8 out of 18 companies in the Healthcare Plans industry, placing it in the top 44.4%.
Is Elevance Health's Return-on-Tangible-Asset too high?
Elevance Health's current Return-on-Tangible-Asset of 6.63% is 25% below median its 10-year median of 8.82. Over the past 10 years, this metric has ranged from a low of 5.90 to a high of 10.64. The Healthcare Plans industry median Return-on-Tangible-Asset is 2.42. Elevance Health's value of 6.63% is 174.5% above this industry median. Based on the distribution chart, Elevance Health ranks #8 out of 18 companies in the Healthcare Plans industry, which is above the industry midpoint. Overall, Elevance Health has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's Return-on-Tangible-Asset compare to CI and HUM?
According to the Healthcare Plans industry distribution chart, Elevance Health ranks #8 out of 18 companies for Return-on-Tangible-Asset. This puts Elevance Health in the upper half of its industry. The industry median Return-on-Tangible-Asset is 2.42. Elevance Health's value of 6.63% is 174.5% above this benchmark. Historically, Elevance Health's own Return-on-Tangible-Asset has ranged from 5.90 to 10.64 over the past decade. While the company's 10-year median is 8.82 vs. the industry median of 2.42, Elevance Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Plans company?
The median Return-on-Tangible-Asset among Healthcare Plans companies is 2.42, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Elevance Health's current Return-on-Tangible-Asset of 6.63% is 174.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Elevance Health and its competitors. For the Healthcare Plans industry, the median Return-on-Tangible-Asset is 2.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elevance Health's current Return-on-Tangible-Asset is 6.63%, which is 25% below median its own 10-year median of 8.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (MEX:ELV) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN8,129.50, compared to a current price of MXN6,449.00 — trading 20.7% below its estimated fair value. The current Return-on-Tangible-Asset is 6.63%, which is 25% below median its 10-year median of 8.82 and 174.5% above the Healthcare Plans industry median of 2.42. Elevance Health's overall GF Score™ is 80/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Elevance Health (MEX:ELV), the current Return-on-Tangible-Asset is 6.63% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elevance Health (MEX:ELV) Overvalued in 2026?
Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued.
The current stock price of MXN6,449.00 is trading 20.7% below its estimated GF Value™ of MXN8,129.50.
GuruFocus considers Elevance Health to be Modestly Undervalued.
Key valuation signals for MEX:ELV:
Return-on-Tangible-Asset: 6.63% (25% below median its 10-year median of 8.82)
GF Value™: MXN8,129.50 vs. price of MXN6,449.00 (20.7% below fair value)
Industry Position: 174.5% above the Healthcare Plans median (#8 of 18)
No single metric tells the full story. See the MEX:ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
80GF Score
Get the complete analysis for MEX:ELV
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ELV has been successfully added to your 
